Clearbridge Health

Clearbridge Health EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Clearbridge Health (1H3.SI) as of Oct 2, 2026 is -2.97. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -1.81 — a change of 64.19% (lower).

EV/FCF

-2.97

YoY

64.19%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Clearbridge Health is 2026 -2.97 . EV/FCF (Enterprise Value to Free Cash Flow) of Clearbridge Health was 2025 -1.81 . It decreases by 64.19% lower compared to the previous year.

The Clearbridge Health EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2017
2.69 SGD
Jan 1, 2018
0.07 SGD
Jan 1, 2019
-1.36 SGD
Jan 1, 2020
7.00 SGD
Jan 1, 2021
-0.65 SGD
Jan 1, 2022
-2.14 SGD
Jan 1, 2023
-1.81 SGD
Jan 1, 2024
-2.97 SGD
The Clearbridge Health EV/FCF history
YEAREV/FCFYoY
-2.97+64.19%
-1.81-15.64%
-2.14+229.91%
-0.65-109.28%
7.00-612.78%
-1.36-2,078.61%
0.07-97.44%
2.69+164,767.85%
0.00-110.26%
-0.02-98.81%
-1.34—
Access this data via the Eulerpool API

Clearbridge Health Stock analysis

What does Clearbridge Health do? Clearbridge Health Ltd is an international company in the healthcare and diagnostics sector based in Singapore. The company was founded in 2017 and focuses on the use of innovative technology, information, and communication systems to provide efficient and precise diagnostics and medical care. The business model of Clearbridge Health is based on a wide range of services and products, divided into three segments: Clinical diagnostics, healthcare services, and digitization. These divisions are interconnected and allow the company to offer a comprehensive range of healthcare services. In the field of clinical diagnostics, the company offers a variety of laboratory and radiology services. Clearbridge Health has a strong presence in Singapore and Indonesia, where it has several diagnostic laboratories specializing in areas such as pathology, microbiology, genetics, and molecular diagnostics. In addition, the company has partnerships with leading diagnostic laboratories worldwide to provide its customers with an even broader range of diagnostic options. In the healthcare services segment, Clearbridge Health offers a wide range of services including diagnosis, treatment, and disease prevention, as well as health management. A key focus in this area is the care of cancer patients. Here, the company has developed a unique self-financing model where it invests in diagnosis and treatment and benefits from the outcomes achieved. The goal is to provide cancer patients with fast diagnosis and comprehensive, personalized treatment. Clearbridge Health has partnerships with leading cancer centers worldwide and utilizes the latest technologies to enable fast and accurate diagnosis. In the digitization segment, Clearbridge Health offers innovative technology solutions to digitalize the healthcare sector and improve efficiency in healthcare delivery. One of the products includes a cloud-based platform for medical imaging called teleradiology. The platform allows for the digital transmission of images from one location to another, saving time and costs and improving efficiency in patient diagnosis and treatment. Clearbridge Health has experienced rapid growth in recent years. The company has expanded its presence in Asia and other parts of the world and continues to pursue an ambitious expansion strategy. The goal is to become a global leader in healthcare and diagnostics. In summary, Clearbridge Health is an innovative company in the healthcare and diagnostics sector that offers a wide range of services and products. The company has a strong presence in Asia and collaborates closely with leading diagnostic laboratories and cancer centers worldwide. Clearbridge Health is committed to improving healthcare delivery and promoting the adoption of innovative technology solutions to enhance efficiency. The company has experienced impressive growth in recent years and continues to pursue an ambitious expansion strategy. Clearbridge Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Clearbridge Health stock

EV/FCF (Enterprise Value to Free Cash Flow) of Clearbridge Health is -2.97 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Clearbridge Health changed from -1.81 to -2.97, representing a 64.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Clearbridge Health since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Clearbridge Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Clearbridge Health

All Key Metrics — Clearbridge Health